Research Article

Labor Induction with Orally Administrated Misoprostol: A Retrospective Cohort Study

Table 1

Maternal and fetal background data, presented per method of induction. Data are presented as numbers (%) or mean (SD). .

MaternalMisoprostol 
()
Dinoproston
()
Amniotomy
()
Balloon catheter
()
Oxytocin
()
Dinoproston
()
value

Age (year)33.9
(5.0)
33.3
(5.0)
33.1
(5.0)
32.7
(5.0)
33.1
(4.9)
32.7
(5.4)
<0.001
Parity
(primiparous%)
1039
(62)
574
(62)
348
(46)
205
(62)
147
(64)
51
(63)
<0.001
BMI (kg/m2)24.5
(4.4)
24.7
(4.5)
24.4
(4.7)
24.0
(4.0)
24.1
(4.3)
24.0
(5.1)
0.13
Maternal reason for induction
()
<0.001
 PE
 (%, )
158
(9)
46
(5)
27
(4)
5
(1.5)
3
(1.5)
8
(10)
 ICP41
(2.5)
11
(1)
10
(1.5)
9
(2.5)
1
(0.5)
1
(1)
 (%, )
 Diabetes 
 (%)
24117001
(1.5)(1)(1)(1)
 HT
 (%, )
1997200
(1)(1)(1)(0.5)
 Others
 (%, )
42
(2.5)
132
(14)
60
(8)
37
(11)
4
(2)
15
(19)
Fetal reason for induction ()<0.001
 Oligohydramnion
 (%, )
15846301406
(9)(5)(4)(4)(7)
 DFM
 (%, )
411131801
(2.5)(1)(4)(2)(1)
 IUGR
 (%, )
24
(1.5)
11
(1)
10
(1.5)
2
(0.5)
3
(1)
11
(14)
 CTG
 (%, )
19
(1)
9
(1)
19
(2.5)
1
(0.5)
03
(4)
 Others
 (%, )
42
(2.5)
132
(14)
15
(2)
7
(2)
1
(0.5)
14
(17)
Gestational age (days)282
(12)
284
(13)
284
(11)
283
(12)
275
(12)
276
(13)
<0.001
Gender
(boys)
921
(55)
504
(54)
414
(55)
173
(52)
130
(57)
40
(49)
0.8
Years of induction
 2009-2010092247130014461
 2012-2013167510282338420

, , and values < 0.05 were considered as statistically significant. . cholestasis. . fetal movements. growth retardation; abnormal CTG.